Clinical Efficacy and Safety Evaluation of Total Hip Arthroplasty Using the CUVIS-joint 150 Robotic System with Automatic Bone Resection Function: A Single-Center Study

Inha University Hospital0 个研究点目标入组 50 人开始时间: 2026年8月10日最近更新: 2026年8月10日

适应症

试验速览

暂无简介。

•1Adults aged 50 years or older
•2Patients who require primary total hip arthroplasty for a hip disorder
•3Patients who voluntarily agree to participate after receiving sufficient information about the study and provide written informed consent

•1Patients with an active infection at the planned surgical site or signs of systemic infection
•2Patients who require revision surgery or revision arthroplasty because of a previous operation at the affected site. However, patients undergoing total hip arthroplasty after removal of internal fixation devices used for a previous fracture may be enrolled at the investigator’s discretion
•3Patients considered unsuitable for robotic bone resection or implant fixation because of severe osteoporosis or bone loss
•4Patients considered unable to undergo postoperative rehabilitation or follow-up because of a neuromuscular disorder or other condition
•5Women who are pregnant or breastfeeding
•6Patients who are unable to provide voluntary informed consent because of cognitive impairment or a similar condition

发起方